Join the Human Papilloma Virus group to help and get support from people like you.
Human Papilloma Virus News (Page 2)
Related terms: HPV Virus, Wart Virus, Human Papillomavirus, HPV
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 – The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics and Gynaecology....
Guidelines Address RT for Management of HPV-Linked Oropharyngeal Cancer
FRIDAY, June 28, 2024 – In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology, recommendations are...
Past-Year Pap Testing Rates Were Lower in 2022 Than 2019
FRIDAY, June 14, 2024 – Past-year Papanicolaou testing rates were lower in 2022 than in 2019, overall, and lower rates were seen in rural versus urban women, according to a study published in online...
At-School Vaccination Boosts HPV Vaccination Coverage
THURSDAY, May 30, 2024 – At-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination coverage among adolescents, according to a study published online May 23 in...
Primary HPV Screening Intervals Could Be Extended
FRIDAY, May 24, 2024 – Primary human papillomavirus (HPV) screening intervals could be extended, with the risk for cervical precancer or worse (CIN2+) eight years after negative HPV screening...
ASCO: HPV Vaccination Positively Affecting More Than Just Cervical Cancer Risk
THURSDAY, May 23, 2024 – Human papillomavirus (HPV) vaccination is associated with reduced odds of several types of HPV-related cancers, not just cervical cancer, according to a study presented at...
HPV Vaccine Is Also Preventing Cancers in Men: Study
FRIDAY, May 24, 2024 – Development and uptake of the human papilloma virus (HPV) vaccine has been crucial in reducing rates of virus-linked cervical cancers in women. Now, the accumulated data...
Time Between HPV Tests for Cervical Cancer Might Be Safely Extended
WEDNESDAY, May 22, 2024 – HPV testing to prevent cervical cancer might not have to happen as often as currently recommended, a new study says. Current standards require women to undergo human...
Quality Improvement Initiative Boosts Early HPV Vaccine Rates
THURSDAY, May 16, 2024 – A multipronged primary care quality improvement initiative increases early human papillomavirus (HPV) vaccine initiation across racial/ethnic, sociodemographic, insurance,...
FDA Approves First Self-Test Collection Kit for HPV
WEDNESDAY, May 15, 2024 – The U.S. Food and Drug Administration has approved a kit that will allow women to collect their own vaginal sample for HPV screening, a move that could increase early...
School Entry Rules Boost Kids' HPV Vaccination Rates
WEDNESDAY, May 1, 2024 – Getting the HPV shot in adolescence can spare kids a lifetime of risk for cervical and other cancers related to the virus, but only half of American kids are up-to-date on...
FDA Approves Merck’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
KENILWORTH, N.J.--(BUSINESS WIRE) June 12, 2020 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Expanded Age Indication for Gardasil 9 in Males
KENILWORTH, N.J.--(BUSINESS WIRE) December 15, 2015 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved...
FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by Five Additional Types of HPV
December 10, 2014 – The U.S. Food and Drug Administration today approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types...
FDA Medwatch Alert: Unapproved Over The Counter Drugs Marketed for Prevention and Treatment of STDs
[Posted 03/06/2008] FDA advised healthcare professionals and consumers that the Agency issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded...